Acopacli 30mg Injection

About

Acopacli Injection contains Paclitaxel, a highly effective taxane antineoplastic agent extensively utilized in the treatment of various solid tumors. Its unique mechanism of action involves promoting the assembly of microtubules from tubulin dimers and, crucially, stabilizing them by preventing their depolymerization. Microtubules are vital components of the cell's cytoskeleton and mitotic spindle, essential for cell division. By disrupting the dynamic equilibrium required for normal cellular function and division, paclitaxel induces cell cycle arrest in the G2/M phase, ultimately leading to programmed cell death (apoptosis) in rapidly proliferating cancer cells. This makes it a cornerstone in the management of advanced breast cancer, ovarian cancer, non-small cell lung cancer, and Kaposi's sarcoma. Paclitaxel is typically administered intravenously, often requiring premedication to mitigate potential hypersensitivity reactions.

Uses

• Ovarian cancer
• Breast cancer
• Non-small cell lung cancer (NSCLC)
• AIDS-related Kaposi's sarcoma

Directions For Use

Administered intravenously by a qualified healthcare professional. Premedication is often required to prevent hypersensitivity reactions. Dosage and infusion schedule are determined by the physician.

Benefits

• Effective against a broad spectrum of solid tumors.
• Improves survival rates in various cancers.
• Often used in combination with other chemotherapies.
• Can reduce tumor burden and progression.
• Well-established efficacy in metastatic settings.
• Offers a valuable option for recurrent cancers.

Side Effects

• Peripheral neuropathy
• Myelosuppression (neutropenia, anemia, thrombocytopenia)
• Hair loss (alopecia)
• Nausea and vomiting
• Muscle and joint pain (arthralgia/myalgia)
• Hypersensitivity reactions
• Diarrhea
• Fatigue
• Stomatitis/mucositis
• Bradycardia
• Hypotension
• Injection site reactions

Safety Measures

• Alcohol - Avoid alcohol, especially if the formulation contains ethanol, as it may exacerbate side effects and interact with other medications.
• Pregnancy - Contraindicated in pregnancy due to significant risk of fetal harm. Effective contraception is essential for both male and female patients during and for a period after treatment.
• Breastfeeding - Not recommended during breastfeeding as paclitaxel may be excreted in breast milk and could cause serious adverse effects in the infant.
• Liver - Use with caution in patients with hepatic impairment. Dose adjustments are often necessary, and liver function should be closely monitored due to increased risk of toxicity.
• Kidney - Generally, no specific dose adjustment is required for renal impairment, but use with caution. Monitor kidney function, especially in severe cases.
• Lung - Rarely, interstitial pneumonitis or pulmonary fibrosis can occur. Monitor for new or worsening respiratory symptoms and discontinue if lung toxicity is suspected.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.